Details for: ATP6V1E1

Gene ID: 529

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: ATP6V1E1

Ensembl ID: ENSG00000131100

Description: ATPase H+ transporting V1 subunit E1

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • placental villous trophoblast CL2000060
    CSI 41.02
    rCSI 63.39%
    PRS 40.64
  • pancreatic D cell CL0000173
    CSI 36.44
    rCSI 35.84%
    PRS 44.79
  • pancreatic A cell CL0000171
    CSI 31.22
    rCSI 32.71%
    PRS 45.16
  • type B pancreatic cell CL0000169
    CSI 21.62
    rCSI 47.86%
    PRS 40
  • pancreatic ductal cell CL0002079
    CSI 15.82
    rCSI 30.76%
    PRS 44.5
  • retina horizontal cell CL0000745
    CSI 15.21
    rCSI 23.19%
    PRS 39.53
  • pancreatic PP cell CL0002275
    CSI 14.41
    rCSI 57.35%
    PRS 57.93
  • epithelial cell of lower respiratory tract CL0002632
    CSI 12.92
    rCSI 10.02%
    PRS 43.01
  • syncytiotrophoblast cell CL0000525
    CSI 12.51
    rCSI 36.02%
    PRS 60.24
  • epithelial cell of lung CL0000082
    CSI 12.46
    rCSI 10.33%
    PRS 41.14
  • melanocyte CL0000148
    CSI 11.98
    rCSI 8.87%
    PRS 36.81
  • renal alpha-intercalated cell CL0005011
    CSI 11.76
    rCSI 15.73%
    PRS 50.86
  • kidney epithelial cell CL0002518
    CSI 11.67
    rCSI 22.27%
    PRS 65.8
  • Hofbauer cell CL3000001
    CSI 10.23
    rCSI 19.32%
    PRS 52.52
  • muscle cell CL0000187
    CSI 9.97
    rCSI 20.48%
    PRS 64.92
  • microcirculation associated smooth muscle cell CL0008035
    CSI 9.7
    rCSI 28.07%
    PRS 45.22
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 9.27
    rCSI 13.14%
    PRS 39.87
  • extravillous trophoblast CL0008036
    CSI 9.06
    rCSI 11.21%
    PRS 38.7
  • transit amplifying cell CL0009010
    CSI 8.75
    rCSI 13.38%
    PRS 58.91
  • retinal ganglion cell CL0000740
    CSI 7.87
    rCSI 17.38%
    PRS 31.81
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 7.1
    rCSI 8.57%
    PRS 50.1
  • pancreatic stellate cell CL0002410
    CSI 7.03
    rCSI 40.89%
    PRS 53.48
  • amacrine cell CL0000561
    CSI 6.83
    rCSI 19.79%
    PRS 34.76
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 6.72
    rCSI 17.38%
    PRS 39.06
  • regular ventricular cardiac myocyte CL0002131
    CSI 6.43
    rCSI 40.13%
    PRS 35.66
  • mesenchymal cell CL0008019
    CSI 6.18
    rCSI 15.71%
    PRS 39.01
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 6.1
    rCSI 17.49%
    PRS 59.9
  • perivascular cell CL4033054
    CSI 5.94
    rCSI 8.12%
    PRS 47.3
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 5.83
    rCSI 8.01%
    PRS 63.34
  • secretory cell CL0000151
    CSI 5.81
    rCSI 6.07%
    PRS 43.29
  • myeloid dendritic cell CL0000782
    CSI 5.57
    rCSI 8.07%
    PRS 58.61
  • colonocyte CL1000347
    CSI 5.35
    rCSI 7.68%
    PRS 49.95
  • elicited macrophage CL0000861
    CSI 5.1
    rCSI 4.68%
    PRS 49.79
  • podocyte CL0000653
    CSI 5.1
    rCSI 22.65%
    PRS 41.32
  • mononuclear phagocyte CL0000113
    CSI 4.74
    rCSI 10.44%
    PRS 46.51
  • ciliated epithelial cell CL0000067
    CSI 4.6
    rCSI 4.04%
    PRS 32.46
  • glutamatergic neuron CL0000679
    CSI 4.43
    rCSI 9.1%
    PRS 37.77
  • pulmonary ionocyte CL0017000
    CSI 4.42
    rCSI 5.38%
    PRS 50.15
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 4.36
    rCSI 4.29%
    PRS 70.27
  • cerebellar granule cell CL0001031
    CSI 4.35
    rCSI 6.4%
    PRS 39.14
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 4.31
    rCSI 10.37%
    PRS 60.37
  • M cell of gut CL0000682
    CSI 4.18
    rCSI 4.44%
    PRS 57.64
  • lung macrophage CL1001603
    CSI 4.15
    rCSI 9.27%
    PRS 48.87
  • pulmonary alveolar type 2 cell CL0002063
    CSI 4.15
    rCSI 6.43%
    PRS 52.7
  • ciliated cell CL0000064
    CSI 4.13
    rCSI 6.69%
    PRS 41.28
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 4.12
    rCSI 5.4%
    PRS 55.57
  • non-classical monocyte CL0000875
    CSI 4.11
    rCSI 6.59%
    PRS 71.33
  • mucus secreting cell CL0000319
    CSI 4.03
    rCSI 6.41%
    PRS 52.83
  • cerebral cortex neuron CL0010012
    CSI 3.89
    rCSI 15.85%
    PRS 40.49
  • double negative thymocyte CL0002489
    CSI 3.88
    rCSI 2.7%
    PRS 50.99
  • alveolar type 1 fibroblast cell CL4028004
    CSI 3.84
    rCSI 4.21%
    PRS 46.49
  • peripheral nervous system neuron CL2000032
    CSI 3.83
    rCSI 5.21%
    PRS 36.54
  • renal interstitial pericyte CL1001318
    CSI 3.82
    rCSI 10.53%
    PRS 39.75
  • glioblast CL0000030
    CSI 3.75
    rCSI 5.98%
    PRS 36.94
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 3.71
    rCSI 2.97%
    PRS 64
  • exhausted T cell CL0011025
    CSI 3.64
    rCSI 61.66%
    PRS 75.43
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 3.63
    rCSI 18.24%
    PRS 53.4
  • corneal epithelial cell CL0000575
    CSI 3.62
    rCSI 10.36%
    PRS 59.79
  • IgG plasma cell CL0000985
    CSI 3.6
    rCSI 4.32%
    PRS 61.84
  • myofibroblast cell CL0000186
    CSI 3.39
    rCSI 4.69%
    PRS 47.77
  • respiratory basal cell CL0002633
    CSI 3.37
    rCSI 3.49%
    PRS 48.35
  • erythroid progenitor cell CL0000038
    CSI 3.35
    rCSI 19.18%
    PRS 53.41
  • astrocyte of the cerebral cortex CL0002605
    CSI 3.17
    rCSI 7.1%
    PRS 28.65
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 3.15
    rCSI 2.39%
    PRS 53.8
  • goblet cell CL0000160
    CSI 3.14
    rCSI 2.97%
    PRS 43.61
  • squamous epithelial cell CL0000076
    CSI 3.14
    rCSI 7.45%
    PRS 48.39
  • intestinal crypt stem cell of colon CL0009043
    CSI 3.09
    rCSI 23.22%
    PRS 62.78
  • skin fibroblast CL0002620
    CSI 3.05
    rCSI 2.63%
    PRS 51.44
  • interstitial cell of Cajal CL0002088
    CSI 3.04
    rCSI 3.87%
    PRS 47.75
  • myoepithelial cell CL0000185
    CSI 2.95
    rCSI 7.47%
    PRS 50.83
  • epithelial cell CL0000066
    CSI 2.9
    rCSI 4.46%
    PRS 44.99
  • common myeloid progenitor CL0000049
    CSI 2.88
    rCSI 2.33%
    PRS 43.18
  • glandular epithelial cell CL0000150
    CSI 2.88
    rCSI 7.58%
    PRS 65.18
  • plasmablast CL0000980
    CSI 2.8
    rCSI 2.2%
    PRS 49.01
  • platelet CL0000233
    CSI 2.76
    rCSI 11.43%
    PRS 52.3
  • club cell CL0000158
    CSI 2.74
    rCSI 4.02%
    PRS 42.37
  • granulocyte CL0000094
    CSI 2.72
    rCSI 4.16%
    PRS 51.49
  • ionocyte CL0005006
    CSI 2.7
    rCSI 2.9%
    PRS 40.59
  • pro-B cell CL0000826
    CSI 2.65
    rCSI 2.19%
    PRS 43.6
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 2.64
    rCSI 7.79%
    PRS 46.69
  • unswitched memory B cell CL0000970
    CSI 2.63
    rCSI 2.22%
    PRS 59.87
  • enteroendocrine cell CL0000164
    CSI 2.61
    rCSI 3.57%
    PRS 45.14
  • plasmacytoid dendritic cell, human CL0001058
    CSI 2.6
    rCSI 1.82%
    PRS 44.3
  • tracheobronchial smooth muscle cell CL0019019
    CSI 2.6
    rCSI 4.59%
    PRS 51.23
  • early lymphoid progenitor CL0000936
    CSI 2.6
    rCSI 2.28%
    PRS 47.55
  • precursor B cell CL0000817
    CSI 2.54
    rCSI 2.22%
    PRS 52.32
  • acinar cell CL0000622
    CSI 2.4
    rCSI 3.51%
    PRS 53.48
  • hematopoietic precursor cell CL0008001
    CSI 2.39
    rCSI 2.46%
    PRS 60.18
  • vascular leptomeningeal cell CL4023051
    CSI 2.39
    rCSI 4.19%
    PRS 35.53
  • pancreatic acinar cell CL0002064
    CSI 2.35
    rCSI 3.12%
    PRS 47.14
  • inhibitory interneuron CL0000498
    CSI 2.32
    rCSI 5.36%
    PRS 35.18
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 2.32
    rCSI 2.28%
    PRS 57.84
  • fibroblast of lung CL0002553
    CSI 2.32
    rCSI 2.16%
    PRS 42.55
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.31
    rCSI 2.35%
    PRS 55.67
  • enterocyte CL0000584
    CSI 2.3
    rCSI 3.71%
    PRS 51.46
  • radial glial cell CL0000681
    CSI 2.29
    rCSI 3.18%
    PRS 42.22
  • Bergmann glial cell CL0000644
    CSI 2.28
    rCSI 3.12%
    PRS 39.54
  • rod bipolar cell CL0000751
    CSI 2.28
    rCSI 4.09%
    PRS 36.45
  • professional antigen presenting cell CL0000145
    CSI 2.27
    rCSI 7.81%
    PRS 74.57
  • colon epithelial cell CL0011108
    CSI 2.25
    rCSI 2.36%
    PRS 40.07
  • enteric neuron CL0007011
    CSI 0.1
    rCSI 1.4%
    PRS 65.1%
  • pluripotent stem cell CL0002248
    CSI 0.2
    rCSI 4.5%
    PRS 67.6%
  • epithelial cell of esophagus CL0002252
    CSI 0.2
    rCSI 2.2%
    PRS 69.8%
  • direct pathway medium spiny neuron CL4023026
    CSI 0.2
    rCSI 5.8%
    PRS 27.5%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.3
    rCSI 3.8%
    PRS 68.0%
  • cytotoxic T cell CL0000910
    CSI 0.3
    rCSI 1.7%
    PRS 54.9%
  • indirect pathway medium spiny neuron CL4023029
    CSI 0.3
    rCSI 7.6%
    PRS 28.4%
  • vasa recta descending limb cell CL1001285
    CSI 0.3
    rCSI 2.7%
    PRS 74.2%
  • endothelial cell of placenta CL0009092
    CSI 0.4
    rCSI 1.8%
    PRS 54.2%
  • helper T cell CL0000912
    CSI 0.4
    rCSI 0.6%
    PRS 51.7%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.4
    rCSI 1.6%
    PRS 28.9%
  • large pre-B-II cell CL0000957
    CSI 0.4
    rCSI 1.2%
    PRS 57.4%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 0.4
    rCSI 1.0%
    PRS 32.9%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.5
    rCSI 2.5%
    PRS 65.2%
  • bronchial goblet cell CL1000312
    CSI 0.5
    rCSI 2.1%
    PRS 64.2%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.5
    rCSI 1.7%
    PRS 31.3%
  • tracheal goblet cell CL1000329
    CSI 0.6
    rCSI 1.3%
    PRS 62.4%
  • mammary gland epithelial cell CL0002327
    CSI 0.6
    rCSI 2.2%
    PRS 58.1%
  • enteroglial cell CL4040002
    CSI 0.6
    rCSI 3.2%
    PRS 51.7%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.6
    rCSI 1.6%
    PRS 33.8%
  • primitive red blood cell CL0002355
    CSI 0.6
    rCSI 3.5%
    PRS 57.6%
  • germinal center B cell CL0000844
    CSI 0.7
    rCSI 1.9%
    PRS 65.7%
  • mature B cell CL0000785
    CSI 0.7
    rCSI 0.6%
    PRS 51.7%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 0.7
    rCSI 2.6%
    PRS 63.1%
  • colon macrophage CL0009038
    CSI 0.7
    rCSI 3.2%
    PRS 65.3%
  • retinal cone cell CL0000573
    CSI 0.7
    rCSI 1.1%
    PRS 34.0%
  • retinal bipolar neuron CL0000748
    CSI 0.7
    rCSI 1.3%
    PRS 33.1%
  • retinal blood vessel endothelial cell CL0002585
    CSI 0.7
    rCSI 1.2%
    PRS 46.3%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 0.7
    rCSI 0.6%
    PRS 46.3%
  • paneth cell CL0000510
    CSI 0.7
    rCSI 1.1%
    PRS 59.8%
  • stromal cell of ovary CL0002132
    CSI 0.7
    rCSI 2.0%
    PRS 58.0%
  • deuterosomal cell CL4033044
    CSI 0.8
    rCSI 2.5%
    PRS 52.4%
  • neural progenitor cell CL0011020
    CSI 0.8
    rCSI 3.4%
    PRS 36.7%
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 0.8
    rCSI 1.7%
    PRS 33.6%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 0.8
    rCSI 0.9%
    PRS 63.0%
  • class switched memory B cell CL0000972
    CSI 0.8
    rCSI 0.6%
    PRS 61.1%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 0.8
    rCSI 1.6%
    PRS 60.4%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.8
    rCSI 5.0%
    PRS 67.3%
  • intestinal tuft cell CL0019032
    CSI 0.8
    rCSI 1.3%
    PRS 47.2%
  • enteroendocrine cell of small intestine CL0009006
    CSI 0.8
    rCSI 1.8%
    PRS 57.1%
  • fraction A pre-pro B cell CL0002045
    CSI 0.8
    rCSI 1.0%
    PRS 65.5%
  • endothelial cell of uterus CL0009095
    CSI 0.8
    rCSI 6.2%
    PRS 68.9%
  • transit amplifying cell of colon CL0009011
    CSI 0.9
    rCSI 1.0%
    PRS 46.3%
  • basophil CL0000767
    CSI 0.9
    rCSI 1.8%
    PRS 64.0%
  • duct epithelial cell CL0000068
    CSI 0.9
    rCSI 1.3%
    PRS 45.5%
  • tissue-resident macrophage CL0000864
    CSI 0.9
    rCSI 4.2%
    PRS 61.9%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 0.9
    rCSI 1.7%
    PRS 27.0%
  • intermediate monocyte CL0002393
    CSI 1.0
    rCSI 1.4%
    PRS 44.5%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 1.0
    rCSI 1.6%
    PRS 30.0%
  • choroid plexus epithelial cell CL0000706
    CSI 1.0
    rCSI 1.7%
    PRS 33.9%
  • common dendritic progenitor CL0001029
    CSI 1.0
    rCSI 1.3%
    PRS 52.2%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 1.0
    rCSI 1.9%
    PRS 58.8%
  • lung secretory cell CL1000272
    CSI 1.1
    rCSI 2.6%
    PRS 40.8%
  • type L enteroendocrine cell CL0002279
    CSI 1.1
    rCSI 2.0%
    PRS 62.5%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 1.1
    rCSI 1.0%
    PRS 39.4%
  • glycinergic amacrine cell CL4030028
    CSI 1.1
    rCSI 2.8%
    PRS 42.7%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 1.1
    rCSI 1.8%
    PRS 28.0%
  • alternatively activated macrophage CL0000890
    CSI 1.1
    rCSI 1.4%
    PRS 55.8%
  • megakaryocyte CL0000556
    CSI 1.1
    rCSI 4.8%
    PRS 58.5%
  • progenitor cell CL0011026
    CSI 1.1
    rCSI 2.4%
    PRS 47.3%
  • dendritic cell, human CL0001056
    CSI 1.1
    rCSI 1.8%
    PRS 49.4%
  • renal intercalated cell CL0005010
    CSI 1.2
    rCSI 10.2%
    PRS 88.6%
  • forebrain radial glial cell CL0013000
    CSI 1.2
    rCSI 3.7%
    PRS 50.4%
  • renal principal cell CL0005009
    CSI 1.2
    rCSI 3.1%
    PRS 48.0%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 1.2
    rCSI 6.3%
    PRS 57.5%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 1.2
    rCSI 7.1%
    PRS 29.3%
  • respiratory hillock cell CL4030023
    CSI 1.2
    rCSI 2.2%
    PRS 58.2%
  • retinal rod cell CL0000604
    CSI 1.2
    rCSI 2.2%
    PRS 41.3%
  • hepatocyte CL0000182
    CSI 1.2
    rCSI 2.2%
    PRS 41.2%
  • lung ciliated cell CL1000271
    CSI 1.2
    rCSI 1.4%
    PRS 33.3%
  • foveolar cell of stomach CL0002179
    CSI 1.2
    rCSI 2.6%
    PRS 57.5%
  • basal cell of epidermis CL0002187
    CSI 1.2
    rCSI 2.2%
    PRS 26.6%
  • lung pericyte CL0009089
    CSI 1.2
    rCSI 3.3%
    PRS 50.0%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 1.3
    rCSI 4.6%
    PRS 26.9%
  • Cajal-Retzius cell CL0000695
    CSI 1.3
    rCSI 10.3%
    PRS 59.4%
  • hematopoietic stem cell CL0000037
    CSI 1.3
    rCSI 0.9%
    PRS 46.6%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.3
    rCSI 1.6%
    PRS 28.0%
  • endocrine cell CL0000163
    CSI 1.3
    rCSI 6.8%
    PRS 78.3%
  • chondrocyte CL0000138
    CSI 1.3
    rCSI 2.1%
    PRS 36.3%
  • enteric smooth muscle cell CL0002504
    CSI 1.4
    rCSI 1.9%
    PRS 45.3%
  • adventitial cell CL0002503
    CSI 1.4
    rCSI 3.3%
    PRS 53.4%
  • mature alpha-beta T cell CL0000791
    CSI 1.4
    rCSI 5.0%
    PRS 61.8%
  • group 3 innate lymphoid cell CL0001071
    CSI 1.4
    rCSI 1.0%
    PRS 45.9%
  • natural T-regulatory cell CL0000903
    CSI 1.4
    rCSI 2.6%
    PRS 76.5%
  • Langerhans cell CL0000453
    CSI 1.4
    rCSI 2.1%
    PRS 59.9%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 1.5
    rCSI 3.6%
    PRS 27.2%
  • OFF-bipolar cell CL0000750
    CSI 1.5
    rCSI 2.1%
    PRS 52.8%
  • conjunctival epithelial cell CL1000432
    CSI 1.5
    rCSI 2.3%
    PRS 43.2%
  • retinal pigment epithelial cell CL0002586
    CSI 1.5
    rCSI 3.0%
    PRS 42.3%
  • respiratory suprabasal cell CL4033048
    CSI 1.5
    rCSI 2.0%
    PRS 47.3%
  • cardiac muscle cell CL0000746
    CSI 1.5
    rCSI 2.2%
    PRS 34.6%
  • thymocyte CL0000893
    CSI 1.6
    rCSI 5.6%
    PRS 78.9%
  • cardiac endothelial cell CL0010008
    CSI 1.6
    rCSI 6.4%
    PRS 41.4%
  • promyelocyte CL0000836
    CSI 1.7
    rCSI 2.4%
    PRS 52.6%
  • lung neuroendocrine cell CL1000223
    CSI 1.7
    rCSI 2.4%
    PRS 47.4%
  • intestinal epithelial cell CL0002563
    CSI 1.7
    rCSI 1.7%
    PRS 42.2%
  • hepatic stellate cell CL0000632
    CSI 1.7
    rCSI 6.2%
    PRS 36.3%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.7
    rCSI 2.9%
    PRS 34.0%
  • mature T cell CL0002419
    CSI 1.7
    rCSI 1.4%
    PRS 59.3%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 1.7
    rCSI 2.7%
    PRS 69.7%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [ATP6V1E1](/details-gene/529) encodes subunit E1 of the vacuolar-type H+-ATPase (V-ATPase), a multi-subunit enzyme complex essential for acidifying various intracellular organelles. This proton pump plays a fundamental role in processes such as protein degradation in lysosomes, receptor-mediated endocytosis, and neurotransmitter loading into synaptic vesicles. The expression profile of [ATP6V1E1](/details-gene/529) indicates its high significance in cells with specialized secretory or transport functions. **Overall**, it is a top marker in [placental villous trophoblast](/details-cell/CL2000060), as well as pancreatic endocrine cells including [pancreatic D cell](/details-cell/CL0000173), [pancreatic A cell](/details-cell/CL0000171), and [type B pancreatic cell](/details-cell/CL0000169). Clinically, mutations in [ATP6V1E1](/details-gene/529) are associated with autosomal-recessive cutis laxa ([108746](https://omim.org/entry/108746)), a disorder of connective tissue ([Link](https://doi.org/10.1016/j.ajhg.2016.12.010)). ## Cellular Roles and Expression Landscape The expression pattern of [ATP6V1E1](/details-gene/529) underscores its critical role in maintaining pH homeostasis in highly active cellular compartments. Its significance is most pronounced in several functionally distinct cell populations. A primary role is suggested in endocrine and exocrine secretion, evidenced by its high Cell Significance Index (CSI) across multiple pancreatic cell types, including [pancreatic D cell](/details-cell/CL0000173) (CSI: 36.44), [pancreatic A cell](/details-cell/CL0000171) (CSI: 31.22), [type B pancreatic cell](/details-cell/CL0000169) (CSI: 21.62), and [pancreatic ductal cell](/details-cell/CL0002079) (CSI: 15.82). This is consistent with the need for V-ATPase activity in acidifying secretory granules for prohormone processing and maturation. Furthermore, [ATP6V1E1](/details-gene/529) appears crucial for placental function, showing the highest overall significance in [placental villous trophoblast](/details-cell/CL2000060) (CSI: 41.02) and high significance in [syncytiotrophoblast cell](/details-cell/CL0000525) (CSI: 12.51) and placental macrophages known as [Hofbauer cell](/details-cell/CL3000001)s (CSI: 10.23). This suggests a role in nutrient transport, endosomal trafficking, and immune function at the maternal-fetal interface. The gene is also a significant marker in specialized epithelial cells involved in ion and fluid transport, such as [renal alpha-intercalated cell](/details-cell/CL0005011) (CSI: 11.76) and [epithelial cell of lung](/details-cell/CL0000082) (CSI: 12.46), consistent with previous findings on V-ATPase distribution in the kidney ([Link](https://pubmed.ncbi.nlm.nih.gov/1533641/)). Finally, its notable expression in [melanocyte](/details-cell/CL0000148) (CSI: 11.98) points to a specific role in melanosome biogenesis and acidification, a process regulated by the MITF-M transcription factor. ## Pathways and Molecular Function Functionally, [ATP6V1E1](/details-gene/529) is an integral component of the V-ATPase complex, directly participating in [proton transmembrane transport](/details-cell/GO:1902600) via [proton-transporting atpase activity, rotational mechanism](/details-cell/GO:0046961). Its localization to numerous organelle membranes, including the [lysosomal membrane](/details-cell/GO:0005765), [endosome](/details-cell/GO:0005768), and [synaptic vesicle membrane](/details-cell/GO:0030672), is critical for a wide range of cellular processes. The gene's involvement in broader biological pathways reflects the downstream consequences of V-ATPase activity. It is implicated in the [Innate immune system](/details-cell/R-HSA-168249), likely through its role in acidifying phagosomes to facilitate pathogen degradation, as seen in the [ROS and RNS production in phagocytes](/details-cell/R-HSA-1222556) pathway. Its function is also central to nutrient uptake and signaling, as highlighted by its participation in [Transferrin endocytosis and recycling](/details-cell/R-HSA-917977) and the regulation of mTORC1 via the [Amino acids regulate mtorc1](/details-cell/R-HSA-9639288) pathway, which senses amino acid levels at the lysosomal surface. Moreover, its role in developmental biology is underscored by its involvement in [MITF-M-regulated melanocyte development](/details-cell/R-HSA-9730414), which is consistent with its high expression in [melanocyte](/details-cell/CL0000148)s and the requirement of V-ATPase for melanosome maturation. The link between V-ATPase and autophagy is also evident from its annotation in the [Regulation of macroautophagy](/details-cell/GO:0016241) process, where lysosomal acidification is the terminal step for autophagosome degradation. ## Research Directions The ubiquitous yet contextually critical role of [ATP6V1E1](/details-gene/529) provides several avenues for future investigation. Its association with autosomal-recessive cutis laxa ([Link](https://doi.org/10.1016/j.ajhg.2016.12.010)) highlights how systemic disruption of V-ATPase function can manifest as a connective tissue disorder, likely through impaired secretion and processing of extracellular matrix components. Based on the available data, several testable hypotheses can be proposed: 1. **Hypothesis 1:** Given its high significance in pancreatic endocrine cells ([pancreatic D cell](/details-cell/CL0000173), [A cell](/details-cell/CL0000171), [B cell](/details-cell/CL0000169)), dysregulation of [ATP6V1E1](/details-gene/529) impairs the acidification of secretory granules, leading to improper processing of prohormones (e.g., proinsulin, proglucagon) and contributing to metabolic dysfunction or diabetes. 2. **Hypothesis 2:** The prominent expression of [ATP6V1E1](/details-gene/529) in [placental villous trophoblast](/details-cell/CL2000060) is essential for receptor-mediated endocytosis and transcytosis of maternal nutrients, particularly iron via transferrin. Reduced [ATP6V1E1](/details-gene/529) function could therefore be a contributing factor to idiopathic intrauterine growth restriction (IUGR). **Experimental Approach for Hypothesis 1:** To investigate the role of [ATP6V1E1](/details-gene/529) in hormone processing, one could utilize CRISPR-Cas9 to knock out the gene in a human pancreatic beta-cell line (e.g., EndoC-βH1). The impact on insulin biosynthesis and secretion could be assessed by measuring the ratio of proinsulin to mature insulin using western blotting or specific ELISAs under both basal and glucose-stimulated conditions. Furthermore, transmission electron microscopy could be employed to examine the morphology and integrity of insulin-containing dense-core vesicles in knockout versus control cells. **Therapeutic Potential:** As [ATP6V1E1](/details-gene/529) is a subunit of a fundamental enzyme complex, it presents a challenging therapeutic target for inhibition due to the high likelihood of systemic toxicity. However, for loss-of-function diseases like cutis laxa, the therapeutic goal would be **activation** or restoration of function. Strategies could include gene replacement therapy to deliver a functional copy of the gene to affected tissues or the development of pharmacological chaperones designed to stabilize the mutant ATP6V1E1 protein, promoting its correct folding and incorporation into the V-ATPase complex. Such approaches would require careful consideration of cell-type specific delivery to mitigate off-target effects.

Genular Protein ID: 3353807900

Symbol: VATE1_HUMAN

Name: V-type proton ATPase subunit E 1

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 1533641

Title: Immunologic evidence that vacuolar H+ ATPases with heterogeneous forms of Mr = 31,000 subunit have different membrane distributions in mammalian kidney.

PubMed ID: 1533641

DOI: 10.1016/s0021-9258(19)50184-3

PubMed ID: 8004105

Title: The E subunit of vacuolar H(+)-ATPase localizes close to the centromere on human chromosome 22.

PubMed ID: 8004105

DOI: 10.1093/hmg/3.2.335

PubMed ID: 8250920

Title: Cloning and tissue distribution of subunits C, D, and E of the human vacuolar H(+)-ATPase.

PubMed ID: 8250920

DOI: 10.1006/bbrc.1993.2434

PubMed ID: 15461802

Title: A genome annotation-driven approach to cloning the human ORFeome.

PubMed ID: 15461802

DOI: 10.1186/gb-2004-5-10-r84

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 10591208

Title: The DNA sequence of human chromosome 22.

PubMed ID: 10591208

DOI: 10.1038/990031

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11399750

Title: Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump.

PubMed ID: 11399750

DOI: 10.1074/jbc.m008768200

PubMed ID: 12036578

Title: A human gene, ATP6E1, encoding a testis-specific isoform of H(+)-ATPase subunit E.

PubMed ID: 12036578

DOI: 10.1016/s0378-1119(02)00542-5

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 20717956

Title: Rab11b and its effector Rip11 regulate the acidosis-induced traffic of V-ATPase in salivary ducts.

PubMed ID: 20717956

DOI: 10.1002/jcp.22388

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 28065471

Title: Mutations in ATP6V1E1 or ATP6V1A cause autosomal-recessive cutis laxa.

PubMed ID: 28065471

DOI: 10.1016/j.ajhg.2016.12.010

PubMed ID: 29993276

Title: H+-ATPase B1 subunit localizes to thick ascending limb and distal convoluted tubule of rodent and human kidney.

PubMed ID: 29993276

DOI: 10.1152/ajprenal.00539.2017

PubMed ID: 32001091

Title: Structure and Roles of V-type ATPases.

PubMed ID: 32001091

DOI: 10.1016/j.tibs.2019.12.007

PubMed ID: 33065002

Title: Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly.

PubMed ID: 33065002

DOI: 10.1016/j.molcel.2020.09.029

PubMed ID: 16959974

Title: The consensus coding sequences of human breast and colorectal cancers.

PubMed ID: 16959974

DOI: 10.1126/science.1133427

Sequence Information:

  • Length: 226
  • Mass: 26145
  • Checksum: DFD0D44E6D9AEA17
  • Sequence:
  • MALSDADVQK QIKHMMAFIE QEANEKAEEI DAKAEEEFNI EKGRLVQTQR LKIMEYYEKK 
    EKQIEQQKKI QMSNLMNQAR LKVLRARDDL ITDLLNEAKQ RLSKVVKDTT RYQVLLDGLV 
    LQGLYQLLEP RMIVRCRKQD FPLVKAAVQK AIPMYKIATK NDVDVQIDQE SYLPEDIAGG 
    VEIYNGDRKI KVSNTLESRL DLIAQQMMPE VRGALFGANA NRKFLD